2 verified briefings on Healthtech. Each story includes a plain-English summary, why it matters, and the concrete action engineering teams should take.
Moderna received $50 million from the Coalition for Epidemic Preparedness Innovations (CEPI) to accelerate its mRNA vaccine for the Bundibugyo ebolavirus. The funding is part of a larger initiative by CEPI to combat a recent outbreak in the Democratic Republic of the Congo.
A cancer treatment known as CAR T-cell therapy is being repurposed to combat autoimmune diseases like multiple sclerosis. Early trials are exploring how this technology, which reprograms a patient's own cells, can be used to treat conditions where the immune system mistakenly attacks the body.